Current FDA-approved GLP-1 drugs available on the market include: Byetta (exenatide) Foundayo (orforglipron) Trulicity (dulaglutide), Victoza, Saxenda, Xultophy (liraglutide) Ozempic, Rybelsus, Wegovy (semaglutide) Mounjaro, Zepbound (tirzepatide) While all GLP-1 drugs can cause weight loss as a side effect, only Wegovy, Saxenda, Foundayo, and Zepbound are FDA approved for weight loss
50mg vials The most common size for individual use, 50mg vials work well with 2.5-5ml bacteriostatic water
Dynamics of human mitochondrial complex I assembly: implications for neurodegenerative diseases
The first chapter was convincing people to embrace an injection
W., Knapple, W
Bangladesh J Med Sci 19(4):692696